In 2014, the FDA issued a warning about the use of morcellation devices for laparoscopic hysterectomies and fibroid removal surgeries after reports showed that the procedures may accelerate the spread of uterine cancer in some women.
Now, lawyers are helping those with cancer, diagnosed or accelerated, after undergoing a laparoscopic procedure file lawsuits. Evidence suggests that the makers of these devices knew of the risks for many years without warning consumers.
Morcellation is a procedure used in laparoscopic surgeries allowing minimally-invasive removal of the uterus or fibroids. Each year, an estimated 100,000 women opt for this type of hysterectomy or myomectomy in order to have smaller scars and shorter recovery periods.
Unfortunately, experts now caution that laparoscopic hysterectomies and fibroid removal surgeries performed with morcellators can significantly increase the spread of cancer in some patients. Lawyers are helping those affected file morcellation lawsuits against the manufacturers of these devices for failing to warn of the risks.
The FDA has now warned against the use of morcellation devices for myomectomies and hysterectomies, and the leading manufacturer of the tools has suspended sales. Experts believe, though, that thousands of women may have already been affected over the past decade.
This year, the FDA and gynecologists cautioned that morcellation surgeries can greatly increase the spread of undetected uterine cancers, and shorten patients’ lifespans. Johnson & Johnson began selling morcellators in 1998, and, at one point, controlled approximately 75 percent of the market with the Gynecare Morcellex, Morcellex Sigma, and Gynecare X-Tract models. Other manufacturers include Karl Storz & Co., Richard Wolf Medical, LiNA Medical, and Blue Endo.
There is no class action lawsuit for those who have been affected by morcellation cancer.
Several families have already filed morcellation cancer lawsuits in federal court and their cases are currently underway. Due to the number of claims expected, these cases may be consolidated to a special multidistrict litigation court.
Based on the FDA warning, experts fear that thousands of women may have experienced an acceleration of uterine cancer due to laparoscopic hysterectomies and other morcellation surgeries. Several families have already filed morcellation cancer lawsuits in federal court. Due to the number of claims expected, these cases may be consolidated to a special multidistrict litigation court.
Lawyers are available to discuss your case today and help determine what compensation is available. Since each case if unique, it is difficult to estimate what a single morcellation cancer case is worth. However, those requiring significant additional medical treatment may be eligible to have those and additional costs reimbursed.
It costs nothing to speak with a lawyer or file a claim, unless you receive an award. If you or a loved one developed or had an acceleration of cancer after a hysterectomy, fibroid removal, or other morcellation procedure, it is important to learn about your legal options.
Defective drug lawsuits can be very complex and are often different from personal injury or medical malpractice cases. For this reason, it is important to find a morcellation cancer lawyer who specializes in this type of claim.
Lawyers handling drug injury lawsuits must have a thorough understanding of medical records, medical device safety research, as well as how to litigate cases in special federal courts against powerful drug companies.
Due to the complexity of these cases, DrugNews only recommends lawyers who specialize in medical device injury cases and have already handled morcellation lawsuits.
For more information regarding the research, warnings, cancer, or litigation related to morcellation devices, or to speak with a lawyer, contact us today. We are available 24 hours a day to help.